Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN"
written by Maria E. Rich, Ping Zhao, Abhinav B. Nagulapally, Jeffrey Bond, Giselle L. Saulnier Sholler,
published by Journal of Cancer Therapy, Vol.8 No.6, 2017

has been cited by the following article(s):

[1]	Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
	2021

[2]	XPO1 Overexpression and Drug Targeting in a Combination Strategy for High-Risk Neuroblastoma
	2021

[3]	Molecular targeting therapies for neuroblastoma: Progress and challenges
	2020

[1]	Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas Nature Communications, 2021 DOI:10.1038/s41467-021-20896-z

[2]	Molecular targeting therapies for neuroblastoma: Progress and challenges Medicinal Research Reviews, 2021 DOI:10.1002/med.21750

[3]	Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas Nature Communications, 2021 DOI:10.1038/s41467-021-20896-z

[4]	Molecular targeting therapies for neuroblastoma: Progress and challenges Medicinal Research Reviews, 2021 DOI:10.1002/med.21750

Follow SCIRP